In this episode recorded live at A4M Longevity Fest, host Tom Blue interviews Harry Bane, CEO of LifespanMD. They discuss a transformative model for private medical practices known as "Entrepreneurial Equity." Moving away from the "slash and burn" tactics of traditional private equity, Bane details how Lifespan.MD partners with physician entrepreneurs to provide infrastructure and scale while preserving clinical autonomy. The conversation covers the organization's origin story, the power of network collaboration, and how independent practices are achieving 30–40% organic growth through partnership.

Key Discussion Points

• The Origin Story: Founder Greg Williams created Lifespan.MD after a personal health crisis where his concierge doctor saved his life. The company was born from a desire to create a succession plan that didn't involve selling to a traditional corporate entity that might degrade the practice.

• Entrepreneurial Equity vs. Private Equity: Unlike traditional investors who often cut staff and costs to "flip" a business in five years, Lifespan.MD utilizes a "long-hold" strategy. They invest in the "connective tissue" between practices rather than stripping them down.

• Separation of Powers: The model is built on a clear distinction: The corporation owns the infrastructure, supply chain, and partnership value, while the physicians retain complete ownership of clinical operations and the "art and science" of medicine.

• The End of the "Island": The partnership removes the isolation of solo practice. Physicians who used to view each other as competitors now collaborate, sharing best practices and operational playbooks to improve the entire network.

• Scaling Technology: By pooling resources, independent practices gain access to enterprise-level technology—such as AI automation through Invisible Technologies—that would be cost-prohibitive for a standalone clinic.

Actionable Insights for Practitioners

• Re-evaluate Succession: If you are a practice owner considering an exit, look for a "partnership model" rather than a buyout. This allows you to monetize equity while ensuring your clinical legacy and patient care standards survive.

• Leverage Collective Bargaining: Utilize the scale of a network to access advanced modalities (like whole-body MRIs or peptides) and better supply chain rates, which can drive organic growth rates of 30–40%.

• Adopt "Connective Tissue": Even if you are not joining a network, move away from the "island" mentality. Seek collaboration with peers to share "secret sauce" rather than hoarding information, as the demand for longevity medicine far outstrips supply.

• Focus on the "Art": Use operational partners to handle the business side (accounting, supply chain) so you can reinvigorate your passion for the "art and science" of medicine.

Featured Resources & Calls to Action

• Organization: LifespanMD – A partnership network for concierge and longevity practices.

• Call to Action: Whether you are an established concierge group looking for a partner or a doctor looking to enter the space, visit LifespanMD to connect with the team.

Analogies for Understanding

• The "Island" vs. The "Connective Tissue": Harry Bane describes the traditional solo practitioner as an "owner operator on their island." Lifespan.MD acts as the "connective tissue," bridging these islands so they can function as a cohesive organism rather than isolated outposts.

The "Lottery Ticket" vs. Tangible Wealth: Tom Blue notes that equity in medical roll-ups is often viewed skeptically as a "lottery ticket" (a low chance of high payout). However, because Lifespan.MD has a proven track record in other industries (insurance, security), the equity here is viewed as "tangible," real wealth.